SLLK, Control Peptide for TSP1 Inhibitor(TFA)
| Size | Price | Stock |
|---|---|---|
| 1mg | $72 | In-stock |
| 5mg | $288 | In-stock |
| 10mg | $504 | In-stock |
| 50 mg | Get quote | |
| 100 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-P0301A |
| M.Wt: | 572.62 |
| Formula: | C23H43F3N6O7 |
| Purity: | >98 % |
| Solubility: | H2O : ≥ 100 mg/mL |
SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor. In Vivo: Akita mice treated with 30 mg/kg LSKL have significantly increased nephrin expression, greater than twofold, compared with renal lysates from either saline controls or SLLK-treated mice[1].TGF-β1 is significantly lower (0.10±0.01 pg/mL) in the plasma of mice receiving LSKL compared with that in plasma of mice receiving SLLK control peptide at day 42 (0.20±0.02 pg/mL; P=0.0001). MRNA expression is assessed in the suprarenal aortic lysates obtained from mice receiving SLLK and LSKL peptides[2].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information- Product Name:
- SLLK, Control Peptide for TSP1 Inhibitor(TFA)
- Cat. No.:
- HY-P0301A
- Quantity:
Your information is safe with us.